HEALTH TECHNOLOGY ASSESSMENT OF EMERGING NEW TECHNOLOGIES WORKING GROUP

Co-Chairs:
Karl Matuszewski MS, PharmD, Senior Director, Clinical Knowledge Service, University HealthSystem Consortium, Oak Brook, IL, USA
Noreen Sullivan BS, President and CEO Technology Assessment Evaluation Group LLC, Encinitas, CA, USA
Sheryl Szeinbach BS, MS, PhD, RPh, Professor, College of Pharmacy, Ohio State University, Columbus, OH USA

Leadership Group:
Amit Chhabra MD, MPH, Outcomes Research Reimbursment Manager, Medtronic, Europe Sarl, Tolochenaz, Switzerland
Eric Faulkner, Senior Director RTI Health Solutions, Director, Genomics Biotech Institute, Research Triangle Park, NC, USA
Mayvis Rebeira MBA, MA, Economist, Ministry of Health, Toronto, ON, Canada
Prabashni Reddy PharmD, MS, RPh, Director of the Center for Drug Policy Partners Healthcare, Charlestown, MA, USA
Jose-Manuel Rodriguez Barrios PharmD, MPH, MSc, Health Economics Reimbursement Manager, Medtronic, Iberia, Madrid, Spain
Enrique Seoane-Vazquez PhD, Assistant Professor Ohio State University, Columbus, OH, USA

Objectives:

Describe the current processes on introducing a new technology (drug, device, diagnostics) to assure safety, effectiveness, technology adoption & diffusion
Describe issues in introducing a new technology including real world monitoring